U. Jaehde et al., DISTRIBUTION KINETICS OF ENOXACIN AND ITS METABOLITE OXOENOXACIN IN EXCRETORY FLUIDS OF HEALTHY-VOLUNTEERS, Antimicrobial agents and chemotherapy, 39(9), 1995, pp. 2092-2097
The distribution kinetics of enoxacin and its main metabolite oxoenoxa
cin in excretory fluids was investigated in 11 healthy volunteers, A s
ingle intravenous dose of 428 mg of enoxacin was given as a l-h infusi
on, Serial samples of plasma, urine, saliva, nasal secretions, tears,
and sweat were drawn and analyzed for enoxacin and oxoenoxacin by reve
rsed-phase high-pressure liquid chromatography, Large differences in t
he concentration-time profiles of the excretory fluids analyzed were o
bserved, Nasal secretions exhibited the highest enoxacin exposure, as
assessed by the area under the concentration-time curve, Excretory flu
id/plasma area under the concentration-time curve ratios were found to
be 1.67 +/- 0.36 for nasal secretions, 0.76 +/- 0.28 for saliva, 0.25
+/ 0.07 for sweat, and 0.23 +/- 0.11 for tears, The elimination half-
life of enoxacin from sweat (8.27 +/- 2.63 h) was significantly longer
than that for plasma (5.10 +/- 0.46 h), Oxoenoxacin was detected in u
rine and saliva and exhibited a higher renal clearance and a lower sal
iva exposure than the parent compound, In contrast to that of the meta
bolite, distribution of enoxacin in saliva was found to be time and pH
dependent, In conclusion, our study revealed considerable differences
in the distribution kinetics of enoxacin among various excretory site
s, Because of distinct acidic and basic properties, the anionic oxomet
abolite significantly differs from the zwitterionic parent compound in
its distribution characteristics.